PharmiWeb.com - Global Pharma News & Resources
01-Aug-2018

Alkermes' Corporate Presentation to be Webcast at the 38th Annual Canaccord Genuity Growth Conference

Alkermes' Corporate Presentation to be Webcast at the 38th Annual Canaccord Genuity Growth Conference

PR Newswire

DUBLIN, Aug. 1, 2018

DUBLIN, Aug. 1, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its corporate presentation will be webcast live at the 38th Annual Canaccord Genuity Growth Conference on Wednesday, Aug. 8, 2018 at 10:30 a.m. ET (3:30 p.m. BST) from Boston. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Sandra Coombs
Investor Relations
+1 781 609 6377

 

View original content with multimedia:http://www.prnewswire.com/news-releases/alkermes-corporate-presentation-to-be-webcast-at-the-38th-annual-canaccord-genuity-growth-conference-300690271.html

SOURCE Alkermes plc

Editor Details

Last Updated: 01-Aug-2018